Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1995
Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion geneM A Webster, R D Cardiff, W J Muller
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1995
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changesS L Nand, M A Webster, B G Wren
Journal of the Optical Society of America. A, Optics and Image Science|June 1, 1990
Orientation and spatial-frequency discrimination for luminance and chromatic gratingsM A Webster, K K De Valois, E Switkes
British Journal of Obstetrics and Gynaecology|September 1, 1985
Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessariesM A Webster, S L Phipps, M D Gillmer
Physical Review Letters|January 22, 2002
Temporal response of a random medium from third-order laser speckle frequency correlationsM A Webster, K J Webb, A M Weiner
Nature Communications|November 23, 2019
The role of cyclone activity in snow accumulation on Arctic sea iceM A Webster, C Parker, L Boisvert, et al.
Obstetrics and Gynecology|May 8, 1998
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study GroupS L Nand, M A Webster, R Baber, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1988
Obstetric high risk screening and prediction of neonatal morbidityM A Webster, S Linder-Pelz, J Martins, et al.
Community Health Studies|January 1, 1990
Obstetric risks and outcomes: birth centre compared with conventional labour wardS Linder-Pelz, M A Webster, J Martins, et al.
Climacteric : the Journal of the International Menopause Society|March 27, 2002
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study GroupS L Nand, M A Webster, R Baber, et al.
Pageof 5